Skip to main content

Table 1 Patient characteristics ( n = 130)

From: Bone Scan Index: a prognostic imaging biomarker for high-risk prostate cancer patients receiving primary hormonal therapy

Patient characteristic

Value

Age (years), median (IQR)

76.0 (69 to 84)

BSI

 

 BSI = 0 (M0), no. (%)

72 (55)

 BSI > 0 (M1), no. (%)

58 (45)

 BSI > 0 (M1), median (IQR)

1.7 (0.7 to 7.4)

PSA (ng/mL), median (IQR)

59 (23 to 232)

Clinical T stage (n = 129)

 

 T1, no. (%)

19 (15)

 T2, no. (%)

29 (22)

 T3, no. (%)

54 (42)

 T4, no. (%)

27 (21)

Gleason score (n = 127)

 

 6, no. (%)

6 (5)

 7, no. (%)

47 (37)

 8, no. (%)

30 (24)

 9, no. (%)

35 (28)

 10, no. (%)

9 (7)

  1. BSI, Bone Scan Index; IQR, interquartile range; PSA, prostate-specific antigen; M, M category in staging system for prostate cancer spreading to distant parts of the body.